Edoxaban Impurity 29 | CAS 2829456-34-8 - Request Quote
Edoxaban Impurity 29
| SZ CAT No: | SZ-E041034 |
| CAS No | 2829456-34-8 |
| Mol.F. | C9H9ClN2O3 : HCl |
| Mol.Wt. | 228.6 : 36.5 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1700085-03-5 (free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Edoxaban Impurity 29 is chemically Ethyl 2-((3-chloropyridin-2-yl)amino)-2-oxoacetate. Edoxaban Impurity 29 is supplied with detailed characterization data compliant with regulatory guideline. Edoxaban Impurity 29 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Edoxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2829456-34-8
Purchase 2829456-34-8
Order 2829456-34-8
Enquire 2829456-34-8
price of 2829456-34-8
2829456-34-8 Supplier
2829456-34-8 Manufacturer
2829456-34-8 Exporter
buy high quality Edoxaban Impurity 29
Purchase Edoxaban Impurity 29
Edoxaban Impurity 29 suppliers
Edoxaban Impurity 29 manufacturers
Edoxaban Impurity 29 price
Order Edoxaban Impurity 29
Enquire Edoxaban Impurity 29
Edoxaban Impurity 29 cost
Edoxaban Impurity 29 Supplier
Edoxaban Impurity 29 Distributor
Edoxaban Impurity 29 for Method Validation
Edoxaban Reference Standard
Edoxaban Impurity 29 for ANDA Filing
Edoxaban Impurity 29 for Forced Degradation Studies
Edoxaban Impurity 29 Identification Standards
Edoxaban Impurity 29 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.